Close Menu

NEW YORK (GenomeWeb) – NanoString today said that its preliminary financial results for the fourth quarter and fiscal year ended December 31, 2018 are expected to beat its previously stated guidance, as well as the consensus Wall Street estimates.

NanoString said that product and service revenue is expected to be approximately $23.5 million for the fourth quarter of 2018, which would exceed the firm's previous guidance range of $22 to $23 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.